High-risk papillomavirus infection is associated with altered antibody responses in genital tract:: Non-specific responses in HPV infection

被引:11
作者
Bard, E
Riethmuller, D
Meillet, D
Prétet, JL
Schaal, JP
Mougin, C
Seillès, E
机构
[1] Lab Univ Immunol EA 3181, Fac Med Pharm, F-25030 Besancon, France
[2] CHU Besancon, Hop St Jacques, Serv Gynecol Obstet, Besancon, France
[3] Fac Med Pharm, Lab Parasitol Mycol EA 482, Besancon, France
关键词
D O I
10.1089/0882824041856996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to gain more information about local humoral immune responses to HPV infection, we quantified IgG, IgM, secretory-IgA (S-IgA), and total-IgA by ELISA, and lysozyme and lactoferrin by TR-IFMA, in cervical and cervicovaginal secretions of 40 healthy women and 28 high-risk HPV infected patients (11 were HPV16(+)). IgG, total-IgA, and S-IgA concentrations in cervicovaginal secretions (p<0.0001) and high IgG and total-IgA concentrations (p<0.001 and p<0.01, respectively) in endocervical secretions were significantly higher in HPV+ patients than in the healthy group. Since the S-IgA/total-IgA ratio was significantly lower in cervicovaginal (7.5%) and endocervical secretions (36.5%) in HPV women compared to the control group (p<0.003 and p<0.001, respectively), HPV could be responsible for an increase in local production of non-secretory IgA (monomeric and dimeric forms). IgG and total-IgA concentrations in cervicovaginal and endocervical secretions fell in the same general percentage range in both HPV16(+) and HPV+ groups (80% and 15%, respectively). However, the S-IgA/total-IgA ratio was much lower in HPV16(+) than in HPV+ women, in both cervicovaginal secretions (3.4%) (p<0.003) and in endocervical secretions (23.3%) (p<0.001). Innate immunity proteins and local S-IgA response could not stop the spread of HPV infection in spite of high lysozyme and lactoferrin concentrations. HPV16(+) disturbed the local humoral immune system, which could partly explain its low clearance.
引用
收藏
页码:381 / 389
页数:9
相关论文
共 43 条
[1]   PROTEIN-SPECIFIC CERVICAL ANTIBODY-RESPONSES TO PRIMARY GENITAL HERPES-SIMPLEX VIRUS TYPE-2 INFECTIONS [J].
ASHLEY, RL ;
COREY, L ;
DALESSIO, J ;
WILSON, P ;
REMINGTON, M ;
BARNUM, G ;
TRETHEWEY, P .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) :20-26
[2]   Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions [J].
Bard, E ;
Riethmuller, D ;
Biichlé, S ;
Meillet, D ;
Prétet, JL ;
Mougin, C ;
Seillès, E .
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2002, 23 (02) :145-162
[3]   Nonspecific secretory immunity in HIV-infected patients with oral candidiasis [J].
Bard, E ;
Laibe, S ;
Clair, S ;
Biichlé, S ;
Millon, L ;
Drobacheff, C ;
Bettinger, D ;
Seillès, E ;
Meillet, D .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) :276-284
[4]  
BELEC L, 1994, J CLIN MICROBIOL, V32, P1249
[5]   CERVICOVAGINAL OVERPRODUCTION OF SPECIFIC IGG TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) CONTRASTS WITH NORMAL OR IMPAIRED IGA LOCAL RESPONSE IN HIV-INFECTION [J].
BELEC, L ;
DUPRE, T ;
PRAZUCK, T ;
TEVIBENISSAN, C ;
KANGA, JM ;
PATHEY, O ;
LU, XS ;
PILLOT, J .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :691-697
[6]   Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions [J].
Belec, L ;
Georges, AJ ;
Hallouin, MC ;
Mohamed, AS ;
MorandJoubert, L ;
GeorgesCourbot, MC .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (02) :157-167
[7]   Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia II. Systemic but not local IgA responses correlate with clearance of HPV-16 [J].
Bontkes, HJ ;
de Gruijl, TD ;
Walboomers, JMM ;
Schiller, JT ;
Dillner, J ;
Helmerhorst, TJM ;
Verheijen, RHM ;
Scheper, RJ ;
Meijer, CJLM .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :409-417
[8]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[9]  
Brandtzaeg P, 1997, Behring Inst Mitt, P1
[10]   Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer [J].
Combita, AL ;
Bravo, MM ;
Touzé, A ;
Orozco, O ;
Coursaget, P .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) :796-803